Fig. 2
Disease status before and after neoadjuvant osimertinib therapy. Positron emission tomography/computed tomography 7 months after diagnosis and 2 months after treatment with neoadjuvant osimertinib. a Right lower lobe pulmonary nodule measuring 15 × 13 mm with maximum standardized uptake (SUVmax) of 2.1. b Interval resolution of tracer activity of thoracic lymph nodes